,i #aaith ,,congress #b;d ,session ,h4 ,r4 #hfea ,,in ,,the ,,house ,,of ,,representatives ,may #d1 #bjbf,ms4 ,castor of ,florida 7for herself1 ,mr4 ,fitzpatrick1 and ,ms4 ,underwood7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to implement certain recommendations to promote the inclusion of pregnant and lactating women in clinical research1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,advancing ,safe ,medications for ,moms and ,babies ,act of #bjbf4 #b4 ,updating ,,fda regulations to include pregnant women in clinical trials 7a7 ,purposes ,the purposes of this section are-- 7#a7 to facilitate compliance with applicable ,federal regulations relating to the protection of pregnant women participating in research as subjects2 and 7#b7 to promote the inclusion of pregnant women in clinical research4 7b7 ,harmonization ,for the purposes specified in subsection 7a71 the ,secretary of ,health and ,human ,services 7referred to in this ,act as the ,secretary71 acting through the ,commissioner of ,food and ,drugs1 shall1 to the extent practicable and consistent with other applicable ,federal statutory law1 issue such regulations as may be appropriate to harmonize the regulations of the ,food and ,drug ,administration relating to the protection of human subjects1 including parts #ej and #ef of title #ba1 ,code of ,federal ,regulations1 with the regulations of the ,department of ,health and ,human ,services relating to the inclusion of pregnant women as subjects in clinical research4 7c7 ,deadline ,the ,secretary of ,health and ,human ,services shall finalize the regulations required by subsection 7b7 not later than #ahj days after the date of enactment of this ,act4 #c4 ,raising awareness of research that includes pregnant and lactating women 7a7 ,in general ,the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary71 in consultation with the heads of other relevant ,federal agencies1 including the ,director of the ,centers for ,disease ,control and ,prevention and the ,director of the ,national ,institutes of ,health1 shall establish and implement an education campaign designed to educate patients1 their families1 health care providers1 and other target audiences on-- 7#a7 how including pregnant and lactating women in clinical research can benefit maternal and infant health2 7#b7 available registries and clinical trials that include pregnant and lactating women2 7#c7 the role registries and other postmarket surveillance activities have in studying drugs used by pregnant and lactating women2 and 7#d7 how pregnant and lactating women can easily identify and enroll in clinical trials or registries4 7b7 ,consultation ,in carrying out this section1 the ,secretary shall consult with-- 7#a7 organizations with expertise related to the health of women and infants1 including such organizations representing populations with high rates of maternal mortality and morbidity2 7#b7 representatives from relevant medical societies with subject matter expertise on pregnant women1 lactating women1 or infants2 7#c7 relevant industry representatives2 and 7#d7 other representatives1 as appropriate4 7c7 ,planning ,in establishing the campaign under subsection 7a71 the ,secretary1 in consultation with the heads of other relevant ,federal agencies1 shall-- 7#a7 conduct a needs assessment to-- 7,a7 evaluate existing resources2 and 7,b7 identify barriers to awareness and opportunities to fill gaps and address barriers2 7#b7 identify target audiences for the campaign2 7#c7 identify resource needs for each target audience and best practices to reach each such audience2 and 7#d7 test appropriate messaging strategies1 including risk communication messaging1 for each target audience4 7d7 ,dissemination ,the ,secretary shall publish on a public website1 and regularly update1 the campaign materials described in this section1 and shall ensure that such website-- 7#a7 includes information on clinical trials and registries enrolling pregnant and lactating women2 and 7#b7 provides a user-friendly interface for patients1 their families1 health care providers1 and other target audiences4 7e7 ,authorization of appropriations ,there is authorized to be appropriated to carry out this section #e1jjj1jjj for each of fiscal years #bjbg through #bjca4 #d4 ,research prioritization process for pregnant and lactating women at the ,eunice ,kennedy ,shriver ,national ,institute of ,child ,health and ,human ,development 7a7 ,in general ,the ,director of the ,national ,institutes of ,health1 acting through the ,director of the ,eunice ,kennedy ,shriver ,national ,institute of ,child ,health and ,human ,development 7referred to in this section as ,,nichd71 shall carry out priority research projects on existing and new drugs prescribed for pregnant and lactating women4 7b7 ,research prioritization process ,the ,director of the ,national ,institutes of ,health shall establish a research prioritization process to determine which proposed research projects should receive priority funding under this section4 ,such research prioritization process shall take into account the following factors3 7#a7 ,the available evidence1 including whether there is an unmet medical need or gap in scientific information relevant to treatment of pregnant and lactating women with specific diseases or conditions4 7#b7 ,the feasibility of research1 including the prevalence of a disease or condition in pregnant and lactating women and the availability of investigators with expertise in studying such disease or condition4 7#c7 ,the potential impact of research1 including the severity of the disease or condition in pregnant and lactating women1 the current cost of treating the disease or condition in pregnant and lactating women1 the frequency of use of the drug in pregnant and lactating women1 and the availability of alternative treatments for the disease or condition in pregnant and lactating women4 7c7 ,consultation ,in developing the research prioritization process described in subsection 7b71 the ,director of the ,national ,institutes of ,health shall seek feedback from-- 7#a7 the existing research networks of the ,,nichd with expertise in clinical research involving pregnant and lactating women2 7#b7 relevant medical societies with subject matter expertise on pregnant women1 lactating women1 or children2 and 7#c7 organizations with expertise related to the health of pregnant women1 lactating women1 or children1 including such organizations representing populations with high rates of maternal mortality and morbidity4 7d7 ,research requirements ,the ,director of the ,national ,institutes of ,health shall ensure that-- 7#a7 research projects carried out under subsection 7a7 are conducted by individuals who have the expertise to rigorously evaluate the best-available scientific research2 and 7#b7 the findings from such research projects are based on a preponderance of the best-available1 peer-reviewed scientific evidence4 7e7 ,public comment ,the ,secretary shall provide an opportunity for public comment on the program under this section4 7f7 ,accountability and oversight 7#a7 ,work plan ,not later than #ahj days after the date of enactment of this ,act1 the ,director of the ,national ,institutes of ,health shall submit to the ,committee on ,health1 ,education1 ,labor1 and ,pensions and the ,committee on ,appropriations of the ,senate and the ,committee on ,energy and ,commerce and the ,committee on ,appropriations of the ,house of ,representatives a work plan for-- 7,a7 funding priority research projects under subsection 7a72 and 7,b7 developing the research prioritization process under subsection 7b74 7#b7 ,reports ,not later than ,october #a of each fiscal year for the #e fiscal years beginning immediately after the date of enactment of this ,act1 the ,director of the ,national ,institutes of ,health shall submit to the ,committee on ,health1 ,education1 ,labor1 and ,pensions and the ,committee on ,appropriations of the ,senate and the ,committee on ,energy and ,commerce and the ,committee on ,appropriations of the ,house of ,representatives a report on the program under this section1 including-- 7,a7 the amount of money obligated or expended in the prior fiscal year for each priority research project under subsection 7a72 7,b7 a description of each such project2 and 7,c7 the rationale for prioritizing each such project according to the process under subsection 7b74 7g7 ,authorization of appropriations ,there is authorized to be appropriated to carry out this section such sums as may be necessary for each of fiscal years #bjbg through #bjca4